Cardiovascular Disease

A cognitive test identified individuals aged 100 years or older who had high levels of cognitive performance, according to study findings published in JAMA Network Open.

The FDA approved the GLP-1 receptor agonist dulaglutide for the reduction of major adverse cardiovascular events for adults with type 2 diabetes who have established cardiovascular disease or multiple CV risk factors, making it the first type 2 diabetes drug approved for primary and secondary prevention populations, according to a press release from Eli Lilly.

We as rheumatologists are blessed with a surfeit of remarkable therapies and capabilities for controlling disease that we only dreamed about a short generation ago. With these capabilities have come new responsibilities that have — in some ways — stretched our scope of practice. Allow me to discuss just a few examples.

In the quest to reduce atherosclerotic CVD, statin therapy has emerged as the gold standard pharmacotherapy.

Cost and clinical effectiveness of an intensive lifestyle intervention in patients at high risk for CVD.

This Valentine’s Day, patients can consider moving on from giving chocolate and flowers and giving their partners the gift of heart health. A survey conducted by Cleveland Clinic found that 66% of people who are in a committed relationship said they are concerned about their partner’s health, and 83% reported that they would participate in a heart-healthy diet if their partner initially agreed to do so.

The American College of Cardiology released a bulletin on the cardiac implications of the coronavirus emphasizing the importance of advising patients with CVD on their potential increased risk for the virus.

Individuals with depression, especially men, may be at increased risk for all-cause and CVD mortality, according to results of a prospective cohort study conducted in China and published in JAMA Network Open.

Some in the medical community were initially skeptical of the first statin to win FDA approval, according to a history of the medication published in Heart Views. Now, 32 years later, research suggests it is patients who are reluctant to fully embrace statin use.

Bariatric surgery can help adolescents with severe obesity reduce their long-term cardiovascular disease risk, according to findings published in Obesity.